---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-279061"
form_type: "8-K"
ticker: "INO"
cik: "0001055726"
company_name: "INOVIO PHARMACEUTICALS, INC."
filed_at: "2024-12-16T23:59:59+00:00"
generated_at: "2026-05-29T02:43:28.385634+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Inovio prices $30M public offering of 10M shares and warrants

## Summary
- 10M shares at $3.00/share plus warrants to buy 10M shares at $3.76, 5-year term.
- Gross proceeds $30M; net proceeds ~$27.6M after discounts and expenses.
- Closing expected December 16, 2024, subject to customary conditions.
- Warrants include 4.99% beneficial ownership limitation (up to 9.99% on election).
- Oppenheimer & Co. and Citizens JMP joint book-runners; Stephens Inc. lead manager.

## SEC filing metadata
- accession: 0001193125-24-279061
- form_type: 8-K
- ticker: INO
- cik: 0001055726
- company_name: INOVIO PHARMACEUTICALS, INC.
- filed_at: 2024-12-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1055726/000119312524279061/0001193125-24-279061-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1055726/000119312524279061/d899983d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-279061
- JSON: https://secwatch.observer/filing/0001193125-24-279061.json
- Plain text: https://secwatch.observer/filing/0001193125-24-279061.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.